Giri Ramsingh

Giri Ramsingh has an extensive work experience history in the medical field. Giri has held various positions in prestigious companies, starting with their current role as Vice President of Clinical Sciences at Obsidian Therapeutics since May 2023. Previously, they worked as a Medical Oncologist at thesecondopinion starting in March 2020. Ramsingh also has experience as an Adjunct Faculty of Medicine and Assistant Professor of Medicine in Hematology at the University of Southern California from October 2012 to July 2018. Giri has held senior positions at Gilead Sciences, Genentech, and Exelixis, serving as an Executive Medical Director, Senior Medical Director, and Medical Director, respectively. Ramsingh's early career involved roles such as Instructor in Oncology and Hematology Medical Oncology Fellow at Washington University School of Medicine in St. Louis and Resident Physician at Cleveland Clinic. Giri also gained experience as a Registrar in Medicine and Senior House Officer at Colchester General Hospital. Ramsingh's initial medical training took place at CHRISTIAN MEDICAL COLLEGE in VELLORE, where they worked as a General Medicine Registrar from March 1999 to January 2002.

Giri Ramsingh earned a Bachelor of Medicine, Bachelor of Surgery (MBBS) degree from Christian Medical College in Vellore, India from 1993 to 1998. Giri later pursued a Doctor of Medicine (MD) degree in Medicine from the same institution from 1999 to 2002.